Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancer

ABSTRACT:

SUBMITTER: Lopez-Tejada A 

PROVIDER: S-EPMC12223764 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature